Drug Database · Clinicians

Chlorphenamine + Ibuprofen + Phenylpropanolamine

Also known as: chlorpheniramine (US name, for chlorphenamine)

Brands (3) Decolgen Sinus Relief, DecolgenR Max, PowerfluShow all

Non-steroidal anti-inflammatory drug (propionic acid derivative) / nasal decongestant / antihistamine; Nasal Decongestant/Antihistamine/Non-Selective COX inhibitor (propionic acid derivative) PH FDA category
Fixed-dose combination.

Controlled precursorRx · Prescription drugOTC · Over-the-counter4 PH products

1988 Convention Table I (norephedrine); FDA-registered oral preparations are exempt from all DDB regulatory requirements except registration and licensing of the importer, exporter and manufacturer; prescription and dispensing follow FDA rules (BR 1 s.2014 Sec. 4(5)). Parenteral preparations are not covered by this exemption (Sec. 4(2)(c)(i)); prescribing a drug preparation containing a controlled chemical otherwise requires a PDEA S-2 license (Sec. 6(3)).; BR 1 s.2014 Sec. 6(14)-(15): preparations with norephedrine/phenylpropanolamine 25 mg or below that are classified over-the-counter may be advertised to the public and distributed as samples; the S-2 license fee schedule (Sec. 6) likewise excludes them. The precursor exemption for oral FDA-registered preparations applies to combinations as well (BR 1 s.2014 Sec. 4(5)). Source: DDB, Updated Lists of Scheduled Controlled Substances (as of 20 July 2026); DDB Board Regulation No. 1, s. 2014 (amending BR 3 s. 2003: licensing, prescriptions, exemptions).

Dispensing: Over-the-counter (OTC) · Prescription (Rx) · Controlled precursor Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat US FDA label

  • Use: INDICATIONS AND USAGE Carefully consider the potential benefits and risks of Ibuprofen Tablets and other treatment options before deciding to use Ibuprofen Tablets. US FDA label

    Kidney dosing: Ibuprofen (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Usual: pain 400 mg every 4 to 6 hours as needed; arthritis 1,200 to 3,200 mg/day in 3 or 4 doses; maximum 3,200 mg/day (label). Lowest effective dose, shortest duration.
    CrCl 30–59 mL/min
    No label dose change. Impaired kidney function is a risk factor for NSAID kidney injury: monitor creatinine, potassium and blood pressure; avoid volume depletion and the ACE inhibitor or ARB plus diuretic combination.
    CrCl 15–29 mL/min
    Not recommended in advanced renal disease (no controlled data); if it must be started, monitor kidney function closely (label, Warnings: Advanced Renal Disease).
    CrCl <15 mL/min (not on dialysis)
    Not recommended in advanced renal disease (no controlled data); if it must be started, monitor kidney function closely (label, Warnings: Advanced Renal Disease).
    Hemodialysis (intermittent)
    Not recommended (advanced renal disease; label). NSAIDs may hasten loss of residual kidney function.
    Peritoneal dialysis
    Not recommended (advanced renal disease; label). NSAIDs may hasten loss of residual kidney function.
    CRRT
    Avoid: NSAIDs can worsen acute kidney injury.
    • Dialyzable? Not stated in the label.
    • Monitoring Creatinine, potassium and blood pressure in CKD, heart failure, liver disease, older adults, or with diuretics, ACE inhibitors or ARBs. Gastrointestinal bleeding; hemoglobin with long-term use.

    From the Ibuprofen monograph (renalcarematters.com, reviewed).

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Capsule: 25 mg/2 mg/200 mg, 200 mg/25 mg/2 mg

Registered products in the Philippines

4 products registered with the Food and Drug Administration (FDA) Philippines list Chlorphenamine + Ibuprofen + Phenylpropanolamine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products4
Philippine FDA-registered products for Chlorphenamine + Ibuprofen + Phenylpropanolamine
Package insert
Decolgen Sinus ReliefIbuprofen + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
200 mg / 25 mg / 2 mg CapsuleClear PVC / Blister Foil x 10's (Box of 100's)
OTC
PT. Medifarma LaboratoriesIndonesia
UH Pharma Inc.Importer: UNILAB, Inc.
DRP-16859-01
Mar 30, 2027
DecolgenR MaxIbuprofen + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
200mg / 25 mg / 2mg CapsuleClear PVC / Blister Foil x 10's (Box of 100's)
OTC
PT. Medifarma LaboratoriesIndonesia
Importer: UNILAB, Inc.
DR-XY47703
Mar 30, 2027
NoneIbuprofen + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
200 mg / 25 mg / 2 mg CapsuleClear PVC / Blister Foil x 10's (Box of 100's)
OTC
PT. Medifarma LaboratoriesIndonesia
Importer: UNILAB, Inc.
DRP-16859
Mar 30, 2027
PowerfluPhenylpropanolamine Hydrochloride + Chlorphenamine Maleate + Ibuprofen
25 mg/2 mg/200 mg CapsulePVC Blister Foil x 10's (Box of 100's)
Rx
PT Medifarma LaboratoriesIndonesia
Importer: UNILAB, Inc.
DR-XY47349
Aug 6, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .